ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -39.26% | 79.56% | -62.39% | -81.28% | -87.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.26% | 79.56% | -62.39% | -81.28% | -87.79% |
| Cost of Revenue | -62.54% | 18.73% | -45.16% | -56.42% | -72.49% |
| Gross Profit | 976.67% | 114.74% | -107.09% | -107.38% | -100.57% |
| SG&A Expenses | -43.94% | 125.85% | -7.22% | -27.42% | -12.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.99% | 177.34% | -25.33% | -42.37% | -45.81% |
| Operating Income | 52.00% | -39.01% | -22.52% | -68.03% | -972.11% |
| Income Before Tax | 42.18% | -48.32% | -34.05% | -71.75% | -1,534.40% |
| Income Tax Expenses | -- | 599.52% | -52.55% | -55.16% | -18,428.57% |
| Earnings from Continuing Operations | 15.31% | -274.43% | -28.13% | -78.87% | -1,104.36% |
| Earnings from Discontinued Operations | 1,266.53% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 163.30% | -292.63% | -28.13% | -78.87% | -1,239.09% |
| EBIT | 52.00% | -39.01% | -22.52% | -68.03% | -972.11% |
| EBITDA | 63.81% | -56.88% | -18.48% | -87.56% | -378.08% |
| EPS Basic | 132.43% | -217.47% | -15.34% | -59.55% | -1,158.54% |
| Normalized Basic EPS | 73.13% | -5.41% | -20.66% | -53.21% | -1,434.29% |
| EPS Diluted | 132.43% | -215.63% | -16.67% | -61.61% | -1,158.54% |
| Normalized Diluted EPS | 73.13% | -5.41% | -20.66% | -53.21% | -1,536.92% |
| Average Basic Shares Outstanding | 95.25% | 18.92% | 11.09% | 12.13% | 7.74% |
| Average Diluted Shares Outstanding | 95.25% | 18.92% | 11.09% | 12.13% | -0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |